Reply to the Letter by Kaya Entitled 'Fluctuation Speed as a New Criterion to Evaluate the Efficiency of Intravitreal Anti-VEGF Drugs'

MeSH terms

• Angiogenesis Inhibitors / administration & dosage
• Angiogenesis Inhibitors / pharmacokinetics
• Aqueous Humor / drug effects
• Aqueous Humor / physiology*
• Bevacizumab / administration & dosage*
• Bevacizumab / pharmacokinetics
• Humans
• Intravitreal Injections
• Retinal Detachment* / drug therapy
• Retinal Detachment* / metabolism
• Retinal Detachment* / physiopathology
• Vascular Endothelial Growth Factor A / antagonists & inhibitors*
• Visual Acuity / drug effects*